Breaking News Headlines Today | Ground News

Holiday Sale — Get 40% off Vantage for yourself or as a gift

Muscular Dystrophy Association image

News from Muscular Dystrophy Association

We’ve assigned a media bias rating of unknown to Muscular Dystrophy Association. You can read more about our methodology here.

Muscular Dystrophy Association’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Muscular Dystrophy Association

Where is Muscular Dystrophy Association located?Muscular Dystrophy Association's Website Muscular Dystrophy Association's Twitter

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Muscular Dystrophy Association News

FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS

Amgen · United States

FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS

85% Center coverage: 13 sources

UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing*See the Story

Muscular Dystrophy Association Announces nearly $2 Million in Collaborative Research Grants ...

United States · United States

Muscular Dystrophy Association Announces nearly $2 Million in Collaborative Research Grants ...

100% Center coverage: 1 sources

New York, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the awarding of seven new collaborative research grants totaling nearly $2 million to advance understanding and treatment of multiple neuromuscular diseases, including amyotrophic lateral sclerosis…See the Story

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference

United States · United States

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference

Open the article to view the coverage from dailyguardian.ca See the Story

Breaking News Topics Related to Muscular Dystrophy Association